IL51087A - 6 -fluoro-9 ,21-dihalogeno-11 -hydroxy-17 -(lower alkanoyloxy)-16 -methyl-pregna-184-diene-3,20-dione compounds,their manufacture and pharmaceutical compositions containing them - Google Patents

6 -fluoro-9 ,21-dihalogeno-11 -hydroxy-17 -(lower alkanoyloxy)-16 -methyl-pregna-184-diene-3,20-dione compounds,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL51087A
IL51087A IL51087A IL5108776A IL51087A IL 51087 A IL51087 A IL 51087A IL 51087 A IL51087 A IL 51087A IL 5108776 A IL5108776 A IL 5108776A IL 51087 A IL51087 A IL 51087A
Authority
IL
Israel
Prior art keywords
dihalogeno
pregna
diene
fluoro
hydroxy
Prior art date
Application number
IL51087A
Other languages
English (en)
Other versions
IL51087A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25717430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL51087(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH1615175A external-priority patent/CH621801A5/de
Priority claimed from LU75903A external-priority patent/LU75903A1/xx
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL51087A0 publication Critical patent/IL51087A0/xx
Publication of IL51087A publication Critical patent/IL51087A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL51087A 1975-12-12 1976-12-10 6 -fluoro-9 ,21-dihalogeno-11 -hydroxy-17 -(lower alkanoyloxy)-16 -methyl-pregna-184-diene-3,20-dione compounds,their manufacture and pharmaceutical compositions containing them IL51087A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1615175A CH621801A5 (en) 1975-12-12 1975-12-12 Process for the preparation of polyhalosteroids
LU75903A LU75903A1 (xx) 1976-09-29 1976-09-29

Publications (2)

Publication Number Publication Date
IL51087A0 IL51087A0 (en) 1977-02-28
IL51087A true IL51087A (en) 1980-06-30

Family

ID=25717430

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51087A IL51087A (en) 1975-12-12 1976-12-10 6 -fluoro-9 ,21-dihalogeno-11 -hydroxy-17 -(lower alkanoyloxy)-16 -methyl-pregna-184-diene-3,20-dione compounds,their manufacture and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US4619921A (xx)
JP (1) JPS5289662A (xx)
AT (2) AT357703B (xx)
AU (1) AU508224B2 (xx)
CA (1) CA1056371A (xx)
DD (1) DD128683A5 (xx)
DE (1) DE2655570A1 (xx)
DK (1) DK143708C (xx)
ES (1) ES454120A1 (xx)
FR (1) FR2334363A1 (xx)
GB (1) GB1537130A (xx)
HU (1) HU175583B (xx)
IE (1) IE44473B1 (xx)
IL (1) IL51087A (xx)
NL (1) NL7613791A (xx)
NZ (1) NZ182836A (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209140B (it) * 1979-11-16 1989-07-10 Prochem Ets 6 alfa-fluoro-prednisolone 17,21-diesteri.
EP0078235A3 (de) * 1981-10-23 1983-06-29 Ciba-Geigy Ag Dihalogenierte Steroide
IT1319663B1 (it) * 2000-11-17 2003-10-23 Farmabios Srl Processo per la preparazione di fluoro-steroidi.
CA2473471A1 (en) 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
WO2006110534A2 (en) 2005-04-07 2006-10-19 Taro Pharmaceuticals U.S.A., Inc. A process for preparing a crystalline form of halobetasol propionate
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) * 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US20140112959A1 (en) 2012-10-18 2014-04-24 MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite Topical steroid composition and method
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB924931A (xx) * 1958-07-09
US3499016A (en) * 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
CH510655A (de) * 1967-11-17 1971-07-31 Ciba Geigy Ag Verfahren zur Herstellung neuer Halogenpregnadiene
US3718673A (en) * 1971-02-01 1973-02-27 Du Pont Process for the preparation of 21-chloro-6,6,9alpha-trifluoro-11beta, alpha, 17alpha-trihydroxy-1,4-pregnadien-3,20-dione 16,17-ketals and selected intermediates
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
IE44473B1 (en) 1981-12-16
DK143708C (da) 1982-03-15
DK143708B (da) 1981-09-28
FR2334363A1 (fr) 1977-07-08
CA1056371A (en) 1979-06-12
US4619921A (en) 1986-10-28
DK557876A (da) 1977-06-13
AT363201B (de) 1981-07-27
AU2047276A (en) 1978-06-15
ES454120A1 (es) 1978-02-16
AU508224B2 (en) 1980-03-13
ATA913976A (de) 1979-12-15
DE2655570A1 (de) 1977-06-16
IE44473L (en) 1977-06-12
ATA81279A (de) 1980-12-15
IL51087A0 (en) 1977-02-28
FR2334363B1 (xx) 1980-03-14
AT357703B (de) 1980-07-25
NL7613791A (nl) 1977-06-14
JPS5289662A (en) 1977-07-27
DD128683A5 (de) 1977-12-07
GB1537130A (en) 1978-12-29
HU175583B (hu) 1980-09-28
NZ182836A (en) 1979-01-11

Similar Documents

Publication Publication Date Title
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL51087A (en) 6 -fluoro-9 ,21-dihalogeno-11 -hydroxy-17 -(lower alkanoyloxy)-16 -methyl-pregna-184-diene-3,20-dione compounds,their manufacture and pharmaceutical compositions containing them
IL51816A (en) Steroids,their preparation and pharmaceutical compositions containing them
IL51076A (en) Glucosamine-3-alkanoyl-dipeptides, their manufacture and ppharmaceutical compositions containing them
IL49405A0 (en) Thieno-pyridine derivatives,their preparation and therapeutic compositions containing them
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
IL50542A (en) Substituted pyridinecarboxamides,their manufacture and pharmaceutical compositions containing them
JPS51118756A (en) Novel steroids * pharmaceutical composition containing same and preparation thereof
IL49122A (en) L-pyroglutamyl-l-histidyl-3-alkyl-prolineamide processes for their preparation and therapeutic compositions containing the same
IL50981A (en) 17-esterified 17 -ethynyl or 17 -acetyl steroids, their preparation and pharmalceutical compositions containing them
IL50797A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL49591A0 (en) A new antibiotic,its manufacture and pharmaceutical compositions containing it
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL48788A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL49864A0 (en) New pentacyclic compounds,their preparation and pharmaceutical compositions containing them
IL49847A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL48937A0 (en) New 13-ethinyl-steroids,their manufacture and pharmaceutical compositions containing them
IL49124A0 (en) Novel d-homosteroids,their manufacture and pharmaceutical compositions containing them
IL49239A (en) O-aminoethyl methylthiophenyl-ketoximes, their preparation and pharmaceutical compositions containing them
CY1147A (en) Diphenylmethane derivatives and pharmaceutical compositions containing them
IL50854A (en) D-homosteroids their manufacture and pharmaceutical compositions containing them
IL50058A0 (en) Polycyclic compounds,their preparation and pharmaceutical compositions containing them